RemSleep Holdings (RMSL) Total Debt Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.82% |
| Sep 30, 2025 | -21.82% |
| Jun 30, 2025 | -14.40% |
| Mar 31, 2025 | -4.78% |
| Dec 31, 2024 | -41.29% |
| Jun 30, 2024 | -16.38% |
| Mar 31, 2024 | -3.31% |
| Dec 31, 2023 | -12.94% |
| Mar 31, 2023 | 9.63% |
| Dec 31, 2022 | -4.55% |
| Jun 30, 2022 | 4.51% |
| Dec 31, 2021 | 19.93% |
| Mar 31, 2021 | 32.68% |
| Dec 31, 2020 | 21.65% |
| Dec 31, 2019 | -22.44% |
| Sep 30, 2019 | -22.39% |
| Jun 30, 2019 | 36.55% |
| Mar 31, 2019 | -30.44% |
| Dec 31, 2018 | -24.94% |
| Sep 30, 2018 | -34.62% |
| Jun 30, 2018 | 29.08% |
| Mar 31, 2018 | 10.76% |
| Dec 31, 2017 | 50.57% |
| Sep 30, 2017 | 40.35% |
| Jun 30, 2017 | 15.96% |